Protective effects of crocin against endogenous Aβ-induced neurotoxicity in N2a/APP695swe cells
- 30 June 2021
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 238 (10) , 2839-2847
Abstract
Alzheimer’s disease (AD) is a most common neurodegenerative disorder worldwide. Because of its complex pathogenesis, the prevention and therapies of AD still are a severe challenge. Evidence suggested that crocin, the major component of saffron, exhibited neuroprotective effects in AD. As such, in this study, N2a/APP695swe cells were enrolled to investigate the effects of crocin on endogenous Aβ-induced neurotoxicity. Crocin (100 and 200 μM) could ameliorate cytotoxicity according to CCK-8 assay and reduce apoptosis in line with Hoechst 33,342 staining and Annexin V-FITC/PI double staining in N2a/APP695swe cells. Reduced ROS generation and elevated MMP were found in N2a/APP695swe cells treated with crocin (100 and 200 μM). Additionally, crocin at concentrations of 100 and 200 μM inhibited the release of cytochrome and attenuated caspases-3 activity in N2a/APP695swe cells. Furthermore, succinylation, crotonylation, 2-hydroxyisobutyrylation, malonylation, and phosphorylation were significantly reduced, while a slight increase of acetylation was found in 100-μM crocin treated N2a/APP695swe cells. Taken together, crocin may be a promising natural product candidate for the effective cure of AD.Keywords
Funding Information
- Guangdong Natural Science Foundation (2018A030313084)
- Administration of Traditional Chinese Medicine of Guangdong Province of China (20191187)
- Medical Scientific Research Foundation of Guangdong Province (A2021224)
- the Public Service Platform Open Project Fund of South China Sea for R&D Marine Biomedicine Resources (2HC18010)
- Project of Educational Commission of Guangdong Province (2020KTSXC047)
- Fund of Guangdong Medical University (GDMUZ2020005)
This publication has 27 references indexed in Scilit:
- Efficacy and Safety of Crocus sativus L. in Patients with Mild Cognitive Impairment: One Year Single-Blind Randomized, with Parallel Groups, Clinical TrialJournal of Alzheimer’s Disease, 2016
- Alzheimer's Disease Costs: What We Know and What We Should Take into AccountJournal of Alzheimer’s Disease, 2014
- The role of protein glycosylation in Alzheimer diseaseThe FEBS Journal, 2013
- Post-translational modifications in signal integrationNature Structural & Molecular Biology, 2010
- A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer’s diseasePsychopharmacology, 2009
- Mitochondrial dysfunction: An early event in Alzheimer pathology accumulates with age in AD transgenic miceNeurobiology of Aging, 2009
- Caspase Gene Expression in the Brain as a Function of the Clinical Progression of Alzheimer DiseaseArchives of Neurology, 2003
- The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to TherapeuticsScience, 2002
- Mitochondria and ApoptosisScience, 1998
- Structural Characterization of an -Amylase Inhibitor from a Wild Common Bean (Phaseolus vulgaris): Insight into the Common Structural Features of Leguminous -Amylase InhibitorsThe Journal of Biochemistry, 1997